Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Sarcoma 3Prostatic Neoplasms 3Stomach Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Breast Neoplasms 2Thyroid Neoplasms 1Thrombosis 1Stroke 1Skin Neoplasms 1Sarcoma, Kaposi 1Rhabdomyosarcoma 1Resectable Pancreatic Carcinoma 1Rectal Neoplasms 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Nevus, Pigmented 1Neoplasms 1Mesothelioma, Malignant 1Melanoma 1Liver Neoplasms 1Liposarcoma 1Glioma 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1

Interventions

Sorafenib 3vandetanib 2alectinib 2Sodium 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Bevacizumab 2tremelimumab 1temsirolimus 1ponatinib 1perflutren 1pembrolizumab 1methyl N-acetylsibirosaminide 1lenvatinib 1gallium 68 PSMA-11 1fosbretabulin 1durvalumab 1combretastatin 1cobimetinib 1cabozantinib 1X-Rays 1Valproic Acid 1Thyroxine 1Technetium Tc 99m Sestamibi 1Sirolimus 1Radiofrequency Ablation 1Presenilin-1 1Paclitaxel 1PLX8394 1Lubricant Eye Drops 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Thyroid Neoplasms × X-Rays × Clear all
NCT03463889 2021-06-29

Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer

University of California, San Francisco

Phase 2 Terminated
12 enrolled 10 charts
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡